Home Page

Emergent's mission is simple—
to protect and enhance life.

As a global specialty pharmaceutical company,
Emergent offers specialized products to
healthcare providers and governments to
address medical needs and emerging
health threats.

Learn More

Emergent BioSolutions
Announces Commencement of
When Issued Trading
of Aptevo Common Stock

LEARN MORE ▶

FDA Completes Pre-Approval
Inspection of Building 55, Our
Large-Scale Manufacturing
Facility for BioThrax

LEARN MORE ▶

Emergard Auto-Injector Platform
for Nerve Agent Antidote Delivery
Selected by U.S. Department of
Defense and Battelle
for Testing and Development

LEARN MORE ▶

Our corporate social
responsibility efforts
are a key part of our
mission to protect and
enhance life for millions
around the world.

VIEW OUR ONLINE
CSR REPORT
 ▶
>

Meet Us

  • Investor Relations

    Robert W. Baird Healthcare Conference
    September 7-8, 2016
    New York, NY

     

  • Investor Relations

    Wells Fargo Healthcare Conference
    September 7-8, 2016
    Boston, MA

     

  • Investor Relations

    Three Part Advisors
    Midwest IDEAS Conference
    August 30-31, 2016
    Chicago, IL

     

Price $33.30 0.45 (1.37%)
 Jul 29 2016 3:59PM

REFRESH